SCHEMBL20248917

SCHEMBL20248917

C=C1C(=O)c2cc(C)ccc2N1CC

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.50
ACHE P22303 3/20 0.48
PARK7 Q99497 1/20 0.47
MAPT P10636 8/20 0.47
KMT2A Q03164 5/20 0.47
MEN1 O00255 4/20 0.47
LMNA P02545 4/20 0.47
POLB P06746 3/20 0.47
RCE1 Q9Y256 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HSP90AA1 P07900 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.44
TP53 P04637 2/20 0.43
KDM4E B2RXH2 1/20 0.42
AGTR1 P30556 1/20 0.41
PDE5A O76074 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20248922 0.84 ALDH1A1 (0.49) ALDH1A1ACHEMAPTKMT2AMEN1
SCHEMBL29862307 0.83 PARK7 (0.68) ALDH1A1ACHEPARK7MAPTKMT2A
SCHEMBL396957 0.83 PARK7 (0.68) ALDH1A1ACHEPARK7MAPTKMT2A
SCHEMBL20248930 0.82 PARK7 (0.71) ALDH1A1PARK7
SCHEMBL16521837 0.80 ACHE (0.56) ALDH1A1ACHEMAPTKMT2AMEN1
SCHEMBL14867085 0.77 ACHE (0.44) ALDH1A1ACHEMAPTKMT2AMEN1
SCHEMBL13546141 0.73 ALDH1A1 (0.65) ALDH1A1ACHEMAPTKMT2AMEN1
SCHEMBL20248919 0.73 ACHE (0.44) ALDH1A1ACHEMAPTKMT2AMEN1
SCHEMBL16048726 0.72 ALDH1A1 (0.60) ALDH1A1ACHEMAPTKMT2AMEN1
SCHEMBL4625552 0.71 ALDH1A1 (0.62) ALDH1A1ACHEMAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180162867-A1 EIS INHIBITORS UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION 2018-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180162867-A1 EIS INHIBITORS EP300, ACAT1, ACAT2 ALDH1A1 1232/4885ACHE 892/4885PARK7 4093/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.